References
- 1. Marino MV, Di Saverio S, Podda M et al. The Application of Indocyanine Green Fluorescence Imaging During Robotic Liver Resection: A Case-Matched Study. World J Surg. 2019;43(10):2595-606.
- 2. Kim HJ, Kim CY, Park EK, et al. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. HPB (Oxford). 2015;17: 159-67.
- 3. De Gasperi A, Mazza E, Prosperi M. Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery? World J Hepatol. 2016;8(7): 355-67.
- 4. Vos JJ, Wietasch JK, Absalom AR et al. Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia. 2014;69:1364-76.
- 5. Ishizawa T, Fukushima N, Shibahara J et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 2009;115:2491-504.
- 6. Kang CH, Chen IS. Indocyanine green fluorescence imaging-guided resection of colorectal liver metastasis. J Cancer Res Pract. 2021;8:109-12.
- 7. Wakabayashi T, Cacciaguerra AB, Abe Y et al. Indocyanine Green Fluorescence Navigation in Liver Surgery: A Systematic Review on Dose and Timing of Administration. Ann Surg. 2022;275(6):1025-1034.
- 8. Tsim NC, Frampton AE, Habib NA, Jiao LR. Surgical treatment for liver cancer. World J Gastroenterol 2010;16(8): 927-933.
- 9. Poultsides GA, Schulick RD, Pawlik TM. Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB (Oxford). 2010;12(1):43-9.
- 10. Nakaseko Y, Ishizawa T, Saiura A. Fluorescence-guided surgery for liver tumors. J Surg Oncol. 2018;118:324-31.
- 11. Lisotti A, Azzaroli F, Buonfiglioli F et al. Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014;59:643-650.
- 12. Mizuguchi T, Kawamoto M, Meguro M, et al. Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today. 2014;44:1-10.
- 13. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009;39:107-116.
- 14. Kokudo N, Makuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 2009;44 Suppl 19:119-121.
- 15. Imamura H, Sano K, Sugawara Y et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16-22.
- 16. Yau T, Tang VYF, Yao TJ et al. Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146:1691-700.e3.
- 17. Nowicki TK, Markiet K, Szurowska E. Diagnostic Imaging of Hepatocellular Carcinoma – A Pictorial Essay. Curr Med Imaging Rev. 2017;13(2):140-53.
- 18. Purich K, Dang JT, Poonja A et al. Intraoperative fluorescence imaging with indocyanine green in hepatic resection for malignancy: a systematic review and meta-analysis of diagnostic test accuracy studies. Surg Endosc. 2020;34(7):2891-903.
- 19. Boogerd LS, Handgraaf HJ, Lam HD et al. Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance. Surg Endosc. 2017;31(2):952-961.
- 20. Mehdorn AS, Beckmann JH, Braun F, et al. Usability of indocyanine green in robot-assisted hepatic surgery. J Clin Med. 2021;10:456.